Related Experiment Videos
Enhanced cell transplantation: preventing apoptosis increases cell survival and ventricular function
Yoshinobu Nakamura1, Tamotsu Yasuda, Richard D Weisel
1Department of Surgery, Division of Cardiac Surgery, Toronto General Research Institute, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
Summary
Enhancing cell survival through anti-apoptosis treatments like Bcl-2 gene therapy or heat shock significantly improves cardiac function after myocardial infarction by reducing cell loss and increasing engrafted cell survival.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Cell Biology
Background:
- Cell transplantation is a promising strategy to restore cardiac function post-myocardial infarction.
- Significant cell loss due to ischemia and apoptosis limits the therapeutic efficacy of current cell transplantation methods.
- Improving the survival of transplanted cells is crucial for enhancing treatment benefits.
Purpose of the Study:
- To investigate whether anti-apoptotic pretreatments can improve the survival of transplanted smooth muscle cells (SMCs) and enhance cardiac function after myocardial infarction.
- To compare the efficacy of Bcl-2 gene transfection and heat shock in promoting SMC survival and cardiac repair.
Main Methods:
- Aortic smooth muscle cells (SMCs) were pretreated with either Bcl-2 gene transfection or heat shock.
- Pretreated SMCs were transplanted into the infarcted myocardium of rats.
- Apoptosis, grafted cell survival, scar area, and cardiac function were assessed using TUNEL staining, real-time PCR, echocardiography, and the Langendorff apparatus.
Main Results:
- Bcl-2 gene transfection significantly reduced SMC apoptosis and increased cell survival compared to controls.
- Heat shock also decreased apoptosis and increased survival, though to a lesser extent than Bcl-2 treatment.
- Both anti-apoptotic strategies reduced scar size and improved fractional area change and overall cardiac function.
- Enhanced cardiac function was directly correlated with the number of surviving engrafted cells.
Conclusions:
- Anti-apoptotic pretreatments effectively reduce grafted SMC loss and improve cell survival post-transplantation.
- Enhanced survival of transplanted cells leads to improved ventricular function and cardiac repair after myocardial infarction.
- Targeting apoptosis is a viable strategy to optimize cell transplantation therapy for heart disease.